ArticleInsights into imaging2026
Median nerve swelling in RA patients: an 8-year longitudinal MRI-based study.
Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesRheumatoid arthritis (RA) patients are prone to carpal tunnel syndrome (CTS). MRI can accurately detect median nerve swelling associated with CTS as well as evaluate synovial inflammation and structural damage. A median nerve cross-sectional area (CSA) of > 15 mm MATERIALS AND
methodsRetrospective study of early RA patients who underwent clinical, serology, radiography, and dynamic contrast-enhanced MRI of the wrist at baseline, year 1, and year 8. Median nerve cross-sectional area (CSA), median nerve enhancement and perfusion, retinacular bowing, synovial inflammation, structural damage and functional impairment were assessed.
results81 early RA patients (age: 54 ± 13 years, F/M: 64/17) were studied. Undue median nerve swelling was present in 25 (31%) at baseline and 37 (46%) of 81 ERA patients at year 8. Undue median nerve swelling was moderately (r = 0.634) related to tenosynovitis volume at baseline but was otherwise not related to synovitis and structural damage at either baseline, year 1, or year 8. Median nerve swelling did not regress long-term. At year 8, CTS symptoms were present in about half of RA patients and were not related to median nerve swelling. Functional impairment at year 8 was more frequent in patients with median nerve swelling.
conclusionUndue median nerve swelling is common in RA patients, is not related to synovitis or structural damage, does not regress with treatment, and is linked to long-term functional impairment. CRITICAL RELEVANCE STATEMENT: Median nerve swelling, indicative of carpal tunnel syndrome, is common in RA patients, does not regress with reduction in synovitis or tenosynovitis after treatment and is associated with more severe and more frequent systemic functional impairment. KEY POINTS: Almost one-third of RA patients fulfilled MRI criteria for carpal tunnel syndrome (CTS) diagnosis at baseline, increasing to almost one-half of patients at year 8. Long-term median nerve swelling is not related to tenosynovitis, synovitis or structural damage. Functional impairment was over twice as common in patients with undue median nerve swelling than those without undue median nerve swelling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.